Although nearly all evidence has shown a negative role of CD44 in tumor progression, some conflicting reports have found a positive prognostic value of CD44 in head and neck cancers, especially in oral cancer[19-22], which indicates that some information regarding CD44 is still uncovered. This evidence concerns the gene CD44 and lip and oral cavity carcinoma.